Searchable abstracts of presentations at key conferences in endocrinology

ea0065oc1.6 | Metabolism and Obesity | SFEBES2019

Metabolic surgery reduces kidney SGLT2 expression in mice

Akalestou Elina , Noriega Livia Lopez , Chabosseau Pauline , Leclerc Isabelle , Rutter Guy

Background: Both metabolic surgery and sodium glucose co-transporter (SGLT2) inhibitors have been demonstrated to improve insulin sensitivity and glucose clearance, but also increase glucagon secretion and cardiovascular health.Aim: To examine the effect of metabolic surgery (Vertical Sleeve Gastrectomy; VSG) on SGLT2 expression in kidney cortex of lean mice.Methods: In order to assess whether exogenous SGLT2 inhibition has the sam...

ea0065p198 | Metabolism and Obesity | SFEBES2019

Modulation of EGFR expression to increase islet transplantation success

Ali Usama , Suba Kinga , Bitsi Stavroula , Alonso Aldara Martin , Patel Yateen , Leclerc Isabelle , Rutter Guy A , Rothery Stephen , Salem Victoria , Tomas Alejandra

Background: Islet transplantation is an established treatment for type 1 diabetes mellitus. However, many recipients do not achieve independence from exogenous insulin since up to 50–70% of islets are lost post-transplant. An important factor determining transplant success is graft vascularisation. The epidermal growth factor receptor (EGFR) is a key pro-survival and proliferation factor. Here, we investigate for the first time if EGFR overexpression in pancreatic islets ...

ea0059p104 | Diabetes & cardiovascular | SFEBES2018

Glucose regulates miR-184 via AMP-activated protein kinase (AMPK) in pancreatic β-cells

Pizza Grazia , Nguyen-Tu Marie-Sophie , Cebola Ines , Yavari Arash , Marchetti Piero , Piemonti Lorenzo , De Koning Eelco , Shapiro AM James , Johnson Paul , Sakamoto Kei , Smith David M , Leclerc Isabelle , Ashrafian Houman , Ferrer Jorge , Martinez-Sanchez Aida

Introduction: Pancreatic β-cells control glucose homeostasis by secreting insulin in response to high glucose. MiRNAs regulate β-cell function and contribute to β-cell failure in type 2 diabetes. MiR-184 regulates β-cell compensatory expansion during pregnancy and obesity and its expression is reduced by glucose through unknown mechanisms. AMPK is a suggested target of antidiabetic drugs and an important energy sensor. Its β-cell-selective inactivation...